MKGAF vs. TMO

Last updated Apr 2, 2026

Compare and contrast key facts about Merck KGaA (MKGAF) and Thermo Fisher Scientific Inc. (TMO).

Performance

MKGAF vs. TMO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Merck KGaA (MKGAF) and Thermo Fisher Scientific Inc. (TMO). The values are adjusted to include any dividend payments, if applicable.

MKGAF vs. TMO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
MKGAF Merck KGaA	-16.08%	1.02%	-3.05%	-15.17%	-23.86%	66.27%	47.91%	14.16%	-4.34%	3.85%
TMO Thermo Fisher Scientific Inc.	-14.57%	11.78%	-1.72%	-3.36%	-17.29%	43.54%	43.72%	45.55%	18.21%	35.03%

Fundamentals

Market Cap MKGAF : $53.86B TMO : $186.44B
EPS MKGAF : $5.99 TMO : $17.77
PE Ratio MKGAF : 20.67 TMO : 27.83
PS Ratio MKGAF : 2.55 TMO : 4.19
PB Ratio MKGAF : 1.88 TMO : 3.49
Total Revenue (TTM) MKGAF : $21.10B TMO : $44.56B
Gross Profit (TTM) MKGAF : $12.34B TMO : $18.02B
EBITDA (TTM) MKGAF : $6.56B TMO : $11.35B

Returns By Period

In the year-to-date period, MKGAF achieves a -16.08% return, which is significantly lower than TMO's -14.57% return. Over the past 10 years, MKGAF has underperformed TMO with an annualized return of 6.52%, while TMO has yielded a comparatively higher 13.56% annualized return.

MKGAF

• 1D: 1.16%
• 1M: -19.41%
• YTD: -16.08%
• 6M: -13.43%
• 1Y: -5.33%
• 3Y*: -10.80%
• 5Y*: -2.19%
• 10Y*: 6.52%

TMO

• 1D: 0.61%
• 1M: -2.66%
• YTD: -14.57%
• 6M: -6.66%
• 1Y: 2.77%
• 3Y*: -4.68%
• 5Y*: 1.90%
• 10Y*: 13.56%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

MKGAF vs. TMO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MKGAF

MKGAF Risk / Return Rank: 30
MKGAF Sharpe Ratio Rank: 35
MKGAF Sortino Ratio Rank: 33
MKGAF Omega Ratio Rank: 33
MKGAF Calmar Ratio Rank: 29
MKGAF Martin Ratio Rank: 23

TMO

TMO Risk / Return Rank: 39
TMO Sharpe Ratio Rank: 43
TMO Sortino Ratio Rank: 38
TMO Omega Ratio Rank: 37
TMO Calmar Ratio Rank: 40
TMO Martin Ratio Rank: 40

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MKGAF vs. TMO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Merck KGaA (MKGAF) and Thermo Fisher Scientific Inc. (TMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	MKGAF	TMO	Difference
Sharpe ratio Return per unit of total volatility	-0.11	0.09	-0.19
Sortino ratio Return per unit of downside risk	0.19	0.38	-0.19
Omega ratio Gain probability vs. loss probability	1.02	1.04	-0.02
Calmar ratio Return relative to maximum drawdown	-0.38	-0.01	-0.37
Martin ratio Return relative to average drawdown	-0.97	-0.02	-0.95
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

MKGAF vs. TMO - Sharpe Ratio Comparison

The current MKGAF Sharpe Ratio is -0.11, which is lower than the TMO Sharpe Ratio of 0.09. The chart below compares the historical Sharpe Ratios of MKGAF and TMO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	MKGAF	TMO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.11	0.09	-0.19
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.05	0.07	-0.12
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.18	0.52	-0.35
Sharpe Ratio (All Time) Calculated using the full available price history	0.14	0.41	-0.26

Correlation

The correlation between MKGAF and TMO is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

MKGAF vs. TMO - Dividend Comparison

MKGAF's dividend yield for the trailing twelve months is around 4.04%, more than TMO's 0.36% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
MKGAF Merck KGaA	4.04%	3.39%	3.11%	3.00%	2.05%	5.09%	0.85%	0.00%	1.48%	1.11%	0.00%	0.00%
TMO Thermo Fisher Scientific Inc.	0.36%	0.30%	0.30%	0.26%	0.22%	0.16%	0.19%	0.23%	0.30%	0.32%	0.43%	0.42%

Drawdowns

MKGAF vs. TMO - Drawdown Comparison

The maximum MKGAF drawdown since its inception was -50.13%, smaller than the maximum TMO drawdown of -71.16%. Use the drawdown chart below to compare losses from any high point for MKGAF and TMO.

Drawdown Indicators

	MKGAF	TMO	Difference
Max Drawdown Largest peak-to-trough decline	-50.13%	-71.16%	+21.03%
Max Drawdown (1Y) Largest decline over 1 year	-24.31%	-27.31%	+3.00%
Max Drawdown (5Y) Largest decline over 5 years	-50.13%	-40.95%	-9.18%
Max Drawdown (10Y) Largest decline over 10 years	-50.13%	-40.95%	-9.18%
Current Drawdown Current decline from peak	-47.15%	-24.98%	-22.17%
Average Drawdown Average peak-to-trough decline	-19.54%	-17.97%	-1.57%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.40%	12.13%	-2.73%

Volatility

MKGAF vs. TMO - Volatility Comparison

Merck KGaA (MKGAF) has a higher volatility of 16.10% compared to Thermo Fisher Scientific Inc. (TMO) at 8.84%. This indicates that MKGAF's price experiences larger fluctuations and is considered to be riskier than TMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MKGAF	TMO	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.10%	8.84%	+7.26%
Volatility (6M) Calculated over the trailing 6-month period	37.71%	19.06%	+18.65%
Volatility (1Y) Calculated over the trailing 1-year period	49.46%	32.87%	+16.59%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	44.08%	26.59%	+17.49%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	38.45%	25.93%	+12.52%

Financials

MKGAF vs. TMO - Profitability Comparison

The chart below illustrates the profitability comparison between Merck KGaA and Thermo Fisher Scientific Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

MKGAF - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Merck KGaA reported a gross profit of 2.96B and revenue of 5.25B. Therefore, the gross margin over that period was 56.4%.

TMO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Thermo Fisher Scientific Inc. reported a gross profit of 5.07B and revenue of 12.22B. Therefore, the gross margin over that period was 41.5%.

MKGAF - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Merck KGaA reported an operating income of 780.71M and revenue of 5.25B, resulting in an operating margin of 14.9%.

TMO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Thermo Fisher Scientific Inc. reported an operating income of 2.26B and revenue of 12.22B, resulting in an operating margin of 18.5%.

MKGAF - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Merck KGaA reported a net income of 318.88M and revenue of 5.25B, resulting in a net margin of 6.1%.

TMO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Thermo Fisher Scientific Inc. reported a net income of 1.97B and revenue of 12.22B, resulting in a net margin of 16.1%.